Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/22: Will Bernanke Show His Hand?
- PFP 5/22: Singular Stock Focus Continues
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/22/2013
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 15.35% |
| TRI TECH HOL | TRIT | 8.82% |
| A M R CP | AAMRQ | 8.29% |
| JAZZ PHARMAC | JAZZ | 6.63% |
| SANTARUS INC | SNTS | 5.29% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Jan 22, 2013, we upgraded Tenet Healthcare Corporation ( THC - Analyst Report ) to Outperform from Neutral based on increasing operating revenues and growth through acquisitions. Moreover, the recent strategic plans of this health care services company are expected to generate growth, enhance capital structure and boost shareholder value.
Why the Upgrade?
Tenet Healthcare has been consistently growing its operating revenues since 2006. Additionally, the company has been steadily expanding its operating capacity via acquisitions and alliances. The renewal of the service contract with Cigna Corp. ( CI - Analyst Report ) in the second half of 2012 is also important for Tenet Healthcare as it is one of the largest contracts owned by it.
The Zacks Consensus Estimate for Tenet Healthcare’s fourth-quarter 2012 revenue stands at $2.52 billion, indicating a 5% improvement over the year-ago quarter.
Moreover, Tenet Healthcare is trying to enhance business growth and optimize capital structure through financial and strategic plans comprising acquisitions, share repurchases, debt repayment and a reverse stock split. While the acquisitions will be directed toward strengthening the company’s main business lines, the issue of new debt has already boosted financial flexibility and improved the debt maturity profile.
Going forward, the planned share buyback will enhance earnings per share and boost shareholder value. Thus, we believe that the plan will be beneficial for the company.
We expect Tenet Healthcare to generate a 74.3% improvement in earnings per share in the fourth quarter of 2012 over the prior-year quarter. Consequently, the Zacks Consensus Estimate stands at 70 cents per share. This healthcare service provider, which carries a Zacks Rank #3 (Hold), is yet to announce the date for its fourth-quarter earnings release.
Other Stocks to Consider
Other stocks in the medical sector that are currently performing well include Acadia Healthcare Company, Inc. ( ACHC - Snapshot Report ) – Zacks Rank #1 (Strong Buy) and MEDNAX, Inc. ( MD - Snapshot Report ) – Zacks Rank #2 (Buy).
Read the full reports :
Analyst Report on THC
Snapshot Report on ACHC
Analyst Report on CI
Snapshot Report on MD